Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Carlsbad, California
- Most recent report
- 10-Q, filed Aug 3, 2026
- Incorporated
- Delaware
- Filings on record
- 264 filings
- On EDGAR
- CIK 1807120
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 8 of 22
News 8 of 38
Prospectuses and Registrations 8 of 11
- S-8 Registration statement for an employee plan Mar 9, 2026
- S-3 Shelf registration statement May 7, 2025
- S-8 Registration statement for an employee plan Mar 10, 2025
- S-8 Registration statement for an employee plan Mar 19, 2024
- S-8 Registration statement for an employee plan Mar 14, 2023
- S-3 Shelf registration statement Apr 27, 2022
- S-8 Registration statement for an employee plan Mar 10, 2022
- S-8 Registration statement for an employee plan Mar 26, 2021
Proxies 8 of 11
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- DEFR14A Apr 30, 2025
- DEFA14A Extra proxy material Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2025
- DEFA14A Extra proxy material Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
- DEFA14A Extra proxy material Apr 13, 2023
Ownership 8 of 155
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 4 Insider reported a trade Jun 11, 2026
- 4 Insider reported a trade Jun 11, 2026
- 4 Insider reported a trade Jun 11, 2026
- 4 Insider reported a trade Jun 11, 2026
- 4 Insider reported a trade Jun 11, 2026
- 4 Insider reported a trade Jun 11, 2026
Other 8 of 27
- ARS Annual report sent to shareholders Apr 23, 2026
- EFFECT Notice that a registration became effective May 16, 2025
- CORRESP Reply to SEC staff May 14, 2025
- UPLOAD Comment letter from SEC staff May 13, 2025
- ARS Annual report sent to shareholders Apr 24, 2025
- ARS Annual report sent to shareholders Apr 25, 2024
- ARS Annual report sent to shareholders Apr 13, 2023
- EFFECT Notice that a registration became effective May 9, 2022
Everything here comes from Design Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.